High and sustained patient satisfaction¹

What do patients think about FIRMAGON^®3,4?

There is high and sustained patient satisfaction with FIRMAGON^® administration.¹

Monthly FIRMAGON^® administration was considered satisfactory by 82% of patients (173/211) at 6 months^1*

Satisfaction was sustained during the maintenance phase, with patient satisfaction rate increased to 83.6% (117/140) at 12 months¹

*Patient satisfaction was the secondary endpoint in a multicentre, long-term, prospective, observational, non-interventional study of FIRMAGON^® patients in the Netherlands with advanced prostate cancer. The primary endpoint was PFS failure rate.

What are your key criteria for achieving a positive administration experience for patients?

For patients, after 1 year of treatment, regular visits with their healthcare team were reported as important:^1*

perceived seeing their urologist every 3 months as ‘just right’¹

perceived monthly nurse visits for maintenance injections as ‘just right’¹

Injection site reactions occurred mainly with the starting dose; but incidence dropped from 33% to 4% with maintenance injections⁵

For nurses, optimising injection technique could also play an important role in patients’ experience of FIRMAGON^® administration^2**

*Patient satisfaction was the secondary endpoint in a multicentre, long-term, prospective, observational, non-interventional study of FIRMAGON® patients in the Netherlands with advanced prostate cancer. The primary endpoint was PFS failure rate.

Secondary endpoints included patient and physician satisfaction scores.

Optimise your injection technique